Rosuvastatin in patients with elevated C-reactive protein.

  title={Rosuvastatin in patients with elevated C-reactive protein.},
  author={K C Mak and Edwin S. Y. Chan},
  journal={The New England journal of medicine},
  volume={360 10},
  pages={1040; author reply 1041-2}
To the Editor: Ridker et al. (Nov. 20 issue) report the results of Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER),1 which showed that rosuvastatin significantly reduced cardiovascular events in patients with elevated levels of C-reactive protein. However, broad application of their results in… CONTINUE READING